We are live on ! Find out more
VIVS

VivoSim Labs

78 hedge funds and large institutions have $22.6M invested in VivoSim Labs in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more capital invested

Capital invested by funds: $16.3M → $22.6M (+$6.29M)

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

0% more funds holding

Funds holding: 7878 (0)

0% more ownership

Funds ownership: 0.2%0.2% (+0%)

48% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 23

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $11K

Holders
78
Holders Change
Holders Change %
0%
% of All Funds
1.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
12
Reduced
23
Closed
14
Calls
Puts
$11K
Net Calls
-$11K
Net Calls Change
-$9K

VIVS Hedge Fund Activity: Q4 2019 in Review

78 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q4 2019, worth a combined $22.6M — up 39% from $16.3M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new VIVS positions and 14 closed out — a net gain of 1 holder — while 12 added to existing stakes and 23 trimmed.

The largest buyer was Essex Investment Management, opening a new position worth an estimated $516K. The largest seller was UBS Group, cutting an estimated $170K.

  • 78 institutional investors held VivoSim Labs (VIVS) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $22.6M of VivoSim Labs stock for Q4 2019, up 39% quarter-over-quarter.
  • 15 funds opened new VivoSim Labs positions in Q4 2019 and 14 closed out, a net change of +1 holder.
  • The largest VivoSim Labs buyer in Q4 2019 was Essex Investment Management, an estimated $516K added.
  • The largest VivoSim Labs seller in Q4 2019 was UBS Group, an estimated $170K sold.

Based on aggregated 13F filings for Q4 2019.